Key Highlights
- OSCR stock climbed nearly 11% during pre-market hours following the announcement of a record quarterly profit totaling $679 million.
- Earnings per share on an adjusted basis reached $2.07, significantly outpacing the $1.06 analyst consensus.
- Total revenue of $4.65 billion fell short of the $4.91 billion projection but represented a 53% year-over-year increase.
- The company’s Individual and Small Group membership base expanded by 57%, totaling 3.17 million members.
- Medical loss ratio demonstrated significant improvement, declining to 70.5% from the prior year’s 75.4%.
Oscar Health Inc. delivered its strongest quarterly financial performance on record Wednesday, propelling OSCR stock upward by nearly 11% during pre-market session.
The health insurance company reported net income of $679 million, translating to $2.07 per diluted share — a substantial increase from the $275 million, or $0.92 per share, recorded in Q1 2025.
This performance dramatically exceeded Wall Street’s expectations, surpassing the $1.06 adjusted EPS consensus by approximately $1.01.
Quarterly revenue reached $4.65 billion, marking a robust 53% climb from the $3.05 billion generated in the same period last year. However, this figure came in below analyst projections of $4.91 billion.
Management reaffirmed its complete 2026 annual guidance across all key performance indicators, demonstrating continued optimism about the company’s trajectory.
Member Base Expansion Drives Performance
Oscar’s membership in Individual and Small Group insurance plans climbed to 3.17 million as of the end of March, compared to 2.02 million during the same quarter last year — representing a robust 57% year-over-year expansion.
This membership growth was partially driven by geographic expansion into Alabama and Mississippi, two new state markets, elevating Oscar’s total presence to 20 states for the 2026 benefit year.
The insurer currently serves customers across 573 counties spanning 93 metropolitan markets nationwide.
Superior Medical Cost Management Sets Oscar Apart
The company’s medical loss ratio — representing the portion of premium dollars allocated to medical claims and quality improvement — improved to 70.5% from 75.4% in the first quarter of 2025.
This metric stands considerably lower than the mid-to-high 80% range reported by numerous competing health insurance providers during the identical timeframe.
Oscar attributed this strong performance to strategic pricing discipline and favorable reserve adjustments totaling $68 million from prior periods.
The selling, general, and administrative expense ratio also showed improvement, contracting to 15.2% from 15.8% previously.
Adjusted EBITDA surged to $727 million, representing more than a doubling from the $329 million achieved in Q1 2025.
Operating earnings similarly more than doubled, climbing to $704 million from $297 million year-over-year.
CEO Mark Bertolini stated the organization remains “on track to significantly expand margins and achieve meaningful profitability in 2026.”
The company operated at a loss throughout most of its history following its 2012 launch. Oscar achieved its first full-year profitability in 2024 under Bertolini’s leadership, who assumed the CEO role in 2023 after previously serving as Aetna’s chief executive.
